Moderna Called on by White House to Ramp Up COVID-19 Vaccine Production

Tensions are growing between the White House and Moderna over vaccine manufacturing, according to an October 7 piece at Politico. That outlet reports that three insiders have advised that Moderna is fighting against White House efforts to scale up international donations of their COVID-19 vaccine during 2022. For months Biden’s administration has been urging Moderna to increase domestic production to make the US an “arsenal of vaccines” for global use. This push comes despite Moderna’s pledge to supply 500 million doses to low- and middle-income nations via COVAX. POTUS’ office argues that Moderna’s reluctance to ramp up production may be due to the expectations that the product would be sold at cost and then given free to countries in need. Moderna’s position has “infuriated” top executive health officials in the US government. “We need them to step up to the plate in the short term and dramatically increase the number of doses they’re delivering to low and middle-income countries,” a senior official offered.

Booster versus Primary Vaccinations

Moderna recently announced that it will construct a vaccine-production hub in Africa to make up to 500 million doses per year, but ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee